Differential Modulation of JAK/STAT3 Signaling and BCL-2 Family Proteins by Tetracycline Analogues in Leukemia Models

Zienab M. Hassan, Doste R. Mamand, Hoda W. El-Gawly, Nagla A. El-Sherbeeny, Hala M. F. Mohammad, Mohamed K. Elkherbetawy, Oscar P. B. Wiklander, Moustapha Hassan

Open source

DOI
10.3390/pharmaceutics18040415
Published
2026-03-28
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18040415,
  title = {Differential Modulation of JAK/STAT3 Signaling and BCL-2 Family Proteins by Tetracycline Analogues in Leukemia Models},
  author = {Zienab M. Hassan and Doste R. Mamand and Hoda W. El-Gawly and Nagla A. El-Sherbeeny and Hala M. F. Mohammad and Mohamed K. Elkherbetawy and Oscar P. B. Wiklander and Moustapha Hassan},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18040415},
  url = {https://doi.org/10.3390/pharmaceutics18040415}
}

RIS

TY  - JOUR
TI  - Differential Modulation of JAK/STAT3 Signaling and BCL-2 Family Proteins by Tetracycline Analogues in Leukemia Models
AU  - Zienab M. Hassan
AU  - Doste R. Mamand
AU  - Hoda W. El-Gawly
AU  - Nagla A. El-Sherbeeny
AU  - Hala M. F. Mohammad
AU  - Mohamed K. Elkherbetawy
AU  - Oscar P. B. Wiklander
AU  - Moustapha Hassan
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18040415
UR  - https://doi.org/10.3390/pharmaceutics18040415
ER  - 

APA

Hassan, Z. M., Mamand, D. R., El-Gawly, H. W., El-Sherbeeny, N. A., Mohammad, H. M. F., Elkherbetawy, M. K., Wiklander, O. P. B., & Hassan, M. (2026). Differential Modulation of JAK/STAT3 Signaling and BCL-2 Family Proteins by Tetracycline Analogues in Leukemia Models. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18040415

Source records